Malvern Institute

Malvern Institute - Pottstown, PA

Malvern Institute is an addiction treatment center situated at 1566 Medical Drive, Suite 201 in the 19464 zip code of Pottstown, PA. It is run by a private for-profit organization. Malvern Institute offers naltrexone administration, buprenorphine maintenance and relapse prevention from naltrexone. Malvern Institute provides outpatient methadone/buprenorphine or naltrexone treatment, regular outpatient treatment and intensive outpatient treatment services. Some of the treatment approaches used by Malvern Institute include brief intervention, motivational interviewing and rational emotive behavioral therapy. It provides residential substance abuse treatment.

Address: 1566 Medical Drive, Suite 201, Pottstown, PA 19464

  1. Types of Care
  2. Service Settings
  3. Opioid Medications used in Treatment
  4. Type of Alcohol Use Disorder Treatment
  5. Type Of Treatment
  6. Pharmacotherapies
  7. Treatment Approaches
  8. Facility Ownership
  9. License/Certification/Accreditation
  10. Payment/Insurance/Funding Accepted
  11. Payment Assistance Available
  12. Assessment/Pre-treatment
  13. Screening & Testing
  14. Transitional Services
  15. Ancillary Services
  16. Counseling Services and Education
  17. Tobacco/Screening Services
  18. Facility Smoking Policy
  19. Age Groups Accepted
  20. Gender Accepted

Here are the full facility listing details on Malvern Institute in Pottstown, PA:

Types of Care:

  • residential substance use treatment

Service Settings:

  • outpatient rehabilitation
  • outpatient day treatment
  • IOT
  • outpatient methadone/buprenorphine or naltrexone treatment
  • regular outpatient treatment

Opioid Medications used in Treatment:

  • Buprenorphine clinical treatment
  • Naltrexone treatment

Type of Alcohol Use Disorder Treatment:

  • Prescribes medication for alcohol use disorder

Type Of Treatment:

  • buprenorphine maintenance
  • prescribes suboxone
  • naltrexone administration
  • relapse prevention from naltrexone

Pharmacotherapies:

  • Buprenorphine with naloxone (Ex. Suboxone)
  • Naltrexone (oral)
  • Naltrexone (extended-release, injectable naltrexone - Vivitrol)
  • Medications for psychiatric disorders

Treatment Approaches:

  • anger management
  • brief intervention
  • cognitive behavioral therapy
  • motivational interviewing
  • rational emotive behavioral therapy
  • relapse prevention treatment
  • counseling for substance abuse
  • trauma counseling
  • 12-step rehab

Facility Ownership:

  • a private for-profit organization

License/Certification/Accreditation:

  • State substance abuse agency
  • Certified by Commission on Accreditation of Rehabilitation Facilities

Payment/Insurance/Funding Accepted:

  • Accepts Medicaid
  • Accepts private health insurance
  • Accepts cash or self-payment
  • Accepts state health insurance

Payment Assistance Available:

  • Sliding fee scale

Assessment/Pre-treatment:

  • Comprehensive substance use assessment
  • Outreach to persons in the community

Screening & Testing:

  • Breathalyzer or blood alcohol testing
  • Drug or alcohol urine screening
  • Screening for substance use

Transitional Services:

  • Aftercare/continuing care
  • Discharge Planning
  • Naloxone and overdose education
  • Outcome follow-up after discharge

Ancillary Services:

  • Case management
  • Housing services
  • Mental health services
  • Self-help groups
  • Social skills development
  • Transportation assistance
  • Mentoring/Peer support

Counseling Services and Education:

  • individual counseling
  • counseling for groups
  • family counseling
  • substance use education
  • hepatitis education, counseling and support
  • HIV and AIDS education
  • health education services

Tobacco/Screening Services:

  • Smoking/tobacco cessation counseling

Facility Smoking Policy:

  • Smoking permitted in designated area

Age Groups Accepted:

  • adult rehab
  • accepts young adults

Gender Accepted:

  • women
  • men

Phone #: 610-647-0330

Other inpatient treatment centers within 75 miles of Malvern Institute: